Lupin launches generic Prozac
Lupin is introducing fluoxetine tablets in dosage strengths of 10 mg and 20 mg.
Lupin’s product, which is the generic of Eli Lilly’s Prozac tablets, 10 mg and 20 mg is indicated for acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to 18 years; and the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder. It also is indicated for the acute and maintenance treatment of binge‑eating and vomiting behaviors in adult patients with moderate to severe bulimia nervosa; and for the acute treatment of panic disorder, with or without agoraphobia, in adult patients.
Fluoxetine tablets, 10 mg and 20 mg had a market value of roughly $53 million, according to IQVIA June 2019 data.
Lupin’s product, which is the generic of Eli Lilly’s Prozac tablets, 10 mg and 20 mg is indicated for acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to 18 years; and the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder. It also is indicated for the acute and maintenance treatment of binge‑eating and vomiting behaviors in adult patients with moderate to severe bulimia nervosa; and for the acute treatment of panic disorder, with or without agoraphobia, in adult patients.
Fluoxetine tablets, 10 mg and 20 mg had a market value of roughly $53 million, according to IQVIA June 2019 data.